The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Global adoption of remote technologies to enable patient-centric oncology clinical trials: Analysis by the Bloomberg New Economy International Cancer Coalition.
 
Robert Michael Daly
Leadership - Quadrant Holdings
Stock and Other Ownership Interests - Baxter (I); Cigna (I); CVS Health; IBM; Lilly (I); Pfizer (I); Quadrant Holdings (I); Walgreens Boots Alliance; Zoetis (I)
Other Relationship - AstraZeneca
 
Otis W. Brawley
Leadership - Agilent; Incyte; Jackson Laboratory for Genomic Medicine; Lyell Immunopharma; PDS Biotechnology
Honoraria - Genentech/Roche; Grail
Consulting or Advisory Role - Genentech/Roche; Grail
Travel, Accommodations, Expenses - Genentech/Roche
 
Mary K. Gospodarowicz
No Relationships to Disclose
 
Olufunmilayo I. Olopade
Employment - CancerIQ (I)
Leadership - CancerIQ
Stock and Other Ownership Interests - 54gene; CancerIQ; HealthWell Solutions; Tempus
Consulting or Advisory Role - Tempus
Research Funding - Color Genomics (Inst); Roche/Genentech (Inst)
(OPTIONAL) Uncompensated Relationships - ACS; Susan G. Komen for the Cure
 
Ibilola Fashoyin
No Relationships to Disclose
 
Victoria Wolodzko Smart
No Relationships to Disclose
 
I-Fen Chang
No Relationships to Disclose
 
Craig L. Tendler
No Relationships to Disclose
 
Geoff Kim
No Relationships to Disclose
 
Charles S. Fuchs
No Relationships to Disclose
 
Lianshan Zhang
No Relationships to Disclose
 
Jeffrey J. Legos
No Relationships to Disclose
 
Cristina Duran
No Relationships to Disclose
 
Chitkala Kalidas
Employment - Bayer
Stock and Other Ownership Interests - Bayer; Merck
Travel, Accommodations, Expenses - Bayer; Bayer
 
Jing Qian
No Relationships to Disclose
 
Justin Finnegan
No Relationships to Disclose
 
Piotr Pilarski
No Relationships to Disclose
 
Amy Silverstein
No Relationships to Disclose
 
Yi-Long Wu
Honoraria - AstraZeneca; BeiGene Beijing; Boehringer Ingelheim; Bristol-Myers Squibb/China; Hengrui Pharmaceutical; Lilly; MSD Oncology; Pfizer; Roche
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Roche; Takeda
Research Funding - BMS (Inst); Boehringer Ingelheim (Inst); Pfizer (Inst); Roche (Inst)
 
Bob T. Li
Research Funding - Ambrx (Inst); Amgen (Inst); AstraZeneca (Inst); Bolt Biotherapeutics (Inst); Daiichi Sankyo (Inst); Hengrui Therapeutics (Inst); Lilly (Inst); MORE Health (Inst); Roche/Genentech (Inst)
Patents, Royalties, Other Intellectual Property - Karger Publishers - Book royalty; Shanghai Jiao Tong University Press - Book royalty; US62/514,661 (Inst); US62/685,057 (Inst)
Travel, Accommodations, Expenses - Jiangsu Hengrui Medicine; MORE Health
(OPTIONAL) Uncompensated Relationships - Amgen; AstraZeneca; Boehringer Ingelheim; Daiichi Sankyo; Genentech; Lilly